レナプロ L-FABP テスト
Contents
1. L FABP ee 1 L FABP Nt BE L FABP gg gCr IM LFABP L FABP 1 1 p lt 0 0001 6600 p lt 0 0001 p lt 0 0001 p lt 0 0001 1000 5 100 10 1 12. 4 L FABP 3 5 1 1N 2 L FABP 3 4 005 37C 72
3. No 1 ILFABP 96 x1 hE 2 6mLx1 3 12mL x1 4 12mL x1 L_FABP 2 0 1 1 0 z g mL 5 2 13mg 6 12mL x 2 0 015 7 50mL x1 8 12mL x 1 1N 9 0ng mL 25mL x1 10 L FABP 400ng mL 0 5mL x1 LEABP 1 96 1 2 2 L FABP ELISA L
4. L FABP L FABP L FABP 2 L FABP LFABP L FABP L FABP ie ja 2 L FABP 1
5. LFABP 50uL 50uL 50L 5 5 20 28C 55 3 5 20 28C 55 3 5 20 28C 25 30 488 492nm 620nm 0ng mL 50uL 100 4 20uL 100 4 100 4 100 4 L L L L Ong mL LFABP 10 LFABP L FABP ng mL 492nm 4
6. 3 350gL 3 100gL 5 20 28C 55 7 3 100 7L 5 20 28C 25 1007L 30 488 492nm 2 488 492nm 620nm L FABP L FABP
7. 1 F 2 3 1N 4 5 1 2 2 8 3 20 28C
8. 7 HH ol L FABP 21 9 50 0 96 7 100 0 97 1 0 01 IM 94 46 7 60 0 91 3 95 8 1 2 3 4 n 70 n 64 n 30 n 30 n 23 2 2 2 3 6 0 5 0 10 3 7 7 89 9 85 7 276 9 227 8 ug gCr p Steel 1 L FABP 2 1 3ng mL 1 0ng mL 0 1 2 L FABP 400ng mL 1 5 2 20 3 8 CV 15 4 Spectra Max 340PC 3 400ng mL LFABP
9. 2 20 80C 2 28 80 1 2 400ng mL 3 L FABP 2 8C 4 5 A
10. 7 10 8 2 RA 9 1 197mg dL 21 8mg dL 24 4mg dL 45mg mL 125mg mL
11. 2012 10 1 22200AMX00932000 L FABP L L FABP 1 RN BD eS RV 3 i x 20 28C 5 6
12. 50 L C1 G1 G1 50 L 1 2 3 4 5 6 7 8 9 10 11 12 1 FABP gt AI OOGQQO 20 mlOOOGOGGGGGGGG 10 cIOoCCCGGGGGGGO 50 p IOOGGGGGCGGGGOG 2 g lOOOGGGGGGGGG 125 rwIO OOGGCGGGGO MM c IOoOOGGGGGGGGO HI OOOOGOGO 3 4 a NY a 2 1 2 3 4 5 6 20L 50 7L 50 100 xL 2000mL 488 492nm 620nm 3 20 28C L FABP 1 2 3 4 5 6 7 8 9 10 11 12
13. 2 1 1000ppm 1 121C 20 2 8C 12 LFABP 96 1 1 Veerkamp JH and Maatman RG Prog Lipid Res 34 17 52 1995 2 33 24 27 2001 3 51 219 224 2003 4 Kamijo A et al J Lab Clin Med 143 23 30 2004 5 Kamijo A etal Am J Pathol 165 1243 1255 2004 6 Kamijo A et al J Lab Clin Med 145 125 133 2005 7 Nakamura T et al Diabetes Care 28 2728 2732 2005 8 Mayer GL and Sugaya T Fats of Life XX 4 12 2006 9 Nakamura T et al Am Kidney Dis 47 439 444 2006 10 Kamijo Ikemori A et al Clin Chim Acta 374 1 7 2006 112 0004 1 10 TEL 03 3814 4081 FAX 03 3814 5957
14. UL 2 1 1 10 TEL 03 3814 4081 1 Nakamura T et al Diabetologia 50 490 492 2007 2 Negishi K et al Kidney Int 72 348 358 2007 3 Yamamoto T et al J Am Soc Nephrol 18 2894 2902 2007 4 Portilla D et al Kidney Int 73 465 472 2008 5 Nakamura K et al Drug Metab Pharmacokinet 23 271 278 2008 6 Nakamura T et al SHOCK 31 454 459 2009 7 NoiriE et al Am Physiol Renal Physiol 296 669 679 2009 8 Nielsen SE et al Diabetes Care 32 1684 1688 2009 9 McMahon BA and Murray PT Kidney Int 77 657 659 2010 20 Nielsen SE et al Diabetes Care 33 1320 1324 2010 7 10 4 TEL 03 5843 4092 7
15. 13 14 15 L FABP 2 50 L L FAPP 50 7L 5 L FABP LTFABP 100 L LTFAPP 20gL L FABP 20 L LTFABP L FABP 5 20 28C 55 LFABP 350 7L
16. 00 2 614 L FABP 200 1 492 100 0742 8 1g 01 LFABP pg gCr 50 04 25 0 207 1 125 0 oo 412 L FABP 6 25 0 080 84 g gCr 0 0034 2 LFABP 400ng mL Ong mL L FABP 14kDa 10 100 1000 L FABP STD ng mL
17. 2 24 L FABP 1 1 2 3 1 1 12mL 15 30 40 2000mL LTFABP L FABP 400ng mL Ong mL 1 A1l1 H1 B 1 Hl 0ng mL 50L LFABP 400ng mL A1 50gL B1 L FABP 400ng mL 50zL 10
Download Pdf Manuals
Related Search